Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Gjærde, Lars Klingen  [Clear All Filters]
Journal Article
Neuendorff NRosa, Gagelmann N, Singhal S, Meckstroth S, Thibaud V, Zhao Y, Mir N, Shih Y-Y, Amaro DMC, Roy M, et al. Hypomethylating agent-based therapies in older adults with acute myeloid leukemia - A joint review by the Young International Society of Geriatric Oncology and European Society for Blood and Marrow Transplantation Trainee Committee. J Geriatr Oncol. 2022.
Gjærde LKlingen, Peczynski C, Polge E, Kröger N, de Latour RPeffault, Finke J, Holler E, Blaise D, Helbig G, Salmenniemi U, et al. Impact of pre-transplantation depression and anxiety on the outcome of allogeneic hematopoietic stem cell transplantation: a study from the Transplant Complications Working Party of the EBMT. Bone Marrow Transplant. 2023.
Rasmussen KK, Santos QDos, MacPherson CRoss, Zucco AG, Gjærde LKlingen, Ilett EE, Lodding I, Helleberg M, Lundgren JD, Nielsen SD, et al. Metabolic Profiling Early Post-Allogeneic Haematopoietic Cell Transplantation in the Context of CMV Infection. Metabolites. 2023;13(9).
Jeppesen H, Gjærde LKlingen, Lindegaard J, Julian HOlsen, Heegaard S, Sengeløv H. Ocular Chronic Graft-Versus-Host Disease and Its Relation to Other Organ Manifestations and Outcomes After Allogeneic Haematopoietic Cell Transplantation. Transplant Cell Ther. 2022.
Horgan C, Serroukh Y, Gjærde LKlingen, Gagelmann N. Recognising inequalities in haematopoietic stem-cell transplantation and cellular therapy training. Lancet Haematol. 2022.
Wegener A, Andersen NSmedegaard, Friis LSmidstrup, Petersen SLykke, Schjødt I, Kornblit B, Sengeløv H, Gjærde LKlingen. Triple-drug GVHD prophylaxis after HLA-matched unrelated donor non-myeloablative allogenic hematopoietic stem cell transplantation. Transplant Cell Ther. 2023.